Cargando…

External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality

Assessing prevalent comorbidities is a common approach in health research for identifying clinical differences between individuals. The objective of this study was to validate and compare the predictive performance of two variants of the Elixhauser comorbidity measures (ECM) for inhospital mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortin, Yannick, Crispo, James A. G., Cohen, Deborah, McNair, Douglas S., Mattison, Donald R., Krewski, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369776/
https://www.ncbi.nlm.nih.gov/pubmed/28350807
http://dx.doi.org/10.1371/journal.pone.0174379
_version_ 1782518131689783296
author Fortin, Yannick
Crispo, James A. G.
Cohen, Deborah
McNair, Douglas S.
Mattison, Donald R.
Krewski, Daniel
author_facet Fortin, Yannick
Crispo, James A. G.
Cohen, Deborah
McNair, Douglas S.
Mattison, Donald R.
Krewski, Daniel
author_sort Fortin, Yannick
collection PubMed
description Assessing prevalent comorbidities is a common approach in health research for identifying clinical differences between individuals. The objective of this study was to validate and compare the predictive performance of two variants of the Elixhauser comorbidity measures (ECM) for inhospital mortality at index and at 1-year in the Cerner Health Facts® (HF) U.S. database. We estimated the prevalence of select comorbidities for individuals 18 to 89 years of age who received care at Cerner contributing health facilities between 2002 and 2011 using the AHRQ (version 3.7) and the Quan Enhanced ICD-9-CM ECMs. External validation of the ECMs was assessed with measures of discrimination [c-statistics], calibration [Hosmer–Lemeshow goodness-of-fit test, Brier Score, calibration curves], added predictive ability [Net Reclassification Improvement], and overall model performance [R(2)]. Of 3,273,298 patients with a mean age of 43.9 years and a female composition of 53.8%, 1.0% died during their index encounter and 1.5% were deceased at 1-year. Calibration measures were equivalent between the two ECMs. Calibration performance was acceptable when predicting inhospital mortality at index, although recalibration is recommended for predicting inhospital mortality at 1 year. Discrimination was marginally better with the Quan ECM compared the AHRQ ECM when predicting inhospital mortality at index (c(Quan) = 0.887, 95% CI: 0.885–0.889 vs. c(AHRQ) = 0.880, 95% CI: 0.878–0.882; p < .0001) and at 1-year (c(Quan) = 0.884, 95% CI: 0.883–0.886 vs. c(AHRQ) = 0.880, 95% CI: 0.878–0.881, p < .0001). Both the Quan and the AHRQ ECMs demonstrated excellent discrimination for inhospital mortality of all-causes in Cerner Health Facts®, a HIPAA compliant observational research and privacy-protected data warehouse. While differences in discrimination performance between the ECMs were statistically significant, they are not likely clinically meaningful.
format Online
Article
Text
id pubmed-5369776
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53697762017-04-06 External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality Fortin, Yannick Crispo, James A. G. Cohen, Deborah McNair, Douglas S. Mattison, Donald R. Krewski, Daniel PLoS One Research Article Assessing prevalent comorbidities is a common approach in health research for identifying clinical differences between individuals. The objective of this study was to validate and compare the predictive performance of two variants of the Elixhauser comorbidity measures (ECM) for inhospital mortality at index and at 1-year in the Cerner Health Facts® (HF) U.S. database. We estimated the prevalence of select comorbidities for individuals 18 to 89 years of age who received care at Cerner contributing health facilities between 2002 and 2011 using the AHRQ (version 3.7) and the Quan Enhanced ICD-9-CM ECMs. External validation of the ECMs was assessed with measures of discrimination [c-statistics], calibration [Hosmer–Lemeshow goodness-of-fit test, Brier Score, calibration curves], added predictive ability [Net Reclassification Improvement], and overall model performance [R(2)]. Of 3,273,298 patients with a mean age of 43.9 years and a female composition of 53.8%, 1.0% died during their index encounter and 1.5% were deceased at 1-year. Calibration measures were equivalent between the two ECMs. Calibration performance was acceptable when predicting inhospital mortality at index, although recalibration is recommended for predicting inhospital mortality at 1 year. Discrimination was marginally better with the Quan ECM compared the AHRQ ECM when predicting inhospital mortality at index (c(Quan) = 0.887, 95% CI: 0.885–0.889 vs. c(AHRQ) = 0.880, 95% CI: 0.878–0.882; p < .0001) and at 1-year (c(Quan) = 0.884, 95% CI: 0.883–0.886 vs. c(AHRQ) = 0.880, 95% CI: 0.878–0.881, p < .0001). Both the Quan and the AHRQ ECMs demonstrated excellent discrimination for inhospital mortality of all-causes in Cerner Health Facts®, a HIPAA compliant observational research and privacy-protected data warehouse. While differences in discrimination performance between the ECMs were statistically significant, they are not likely clinically meaningful. Public Library of Science 2017-03-28 /pmc/articles/PMC5369776/ /pubmed/28350807 http://dx.doi.org/10.1371/journal.pone.0174379 Text en © 2017 Fortin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fortin, Yannick
Crispo, James A. G.
Cohen, Deborah
McNair, Douglas S.
Mattison, Donald R.
Krewski, Daniel
External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality
title External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality
title_full External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality
title_fullStr External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality
title_full_unstemmed External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality
title_short External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality
title_sort external validation and comparison of two variants of the elixhauser comorbidity measures for all-cause mortality
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369776/
https://www.ncbi.nlm.nih.gov/pubmed/28350807
http://dx.doi.org/10.1371/journal.pone.0174379
work_keys_str_mv AT fortinyannick externalvalidationandcomparisonoftwovariantsoftheelixhausercomorbiditymeasuresforallcausemortality
AT crispojamesag externalvalidationandcomparisonoftwovariantsoftheelixhausercomorbiditymeasuresforallcausemortality
AT cohendeborah externalvalidationandcomparisonoftwovariantsoftheelixhausercomorbiditymeasuresforallcausemortality
AT mcnairdouglass externalvalidationandcomparisonoftwovariantsoftheelixhausercomorbiditymeasuresforallcausemortality
AT mattisondonaldr externalvalidationandcomparisonoftwovariantsoftheelixhausercomorbiditymeasuresforallcausemortality
AT krewskidaniel externalvalidationandcomparisonoftwovariantsoftheelixhausercomorbiditymeasuresforallcausemortality